AIFinancial Timesabout 3 hours ago
Tempus AI Product Gets FDA Clearance for Pulmonary Hypertension Detection
1 min read
Tempus received FDA clearance for its AI product designed to detect signs of pulmonary hypertension from standard ECGs. The company announced the regulatory approval, marking a step forward for AI-assisted cardiac diagnostics using routine electrocardiogram data.
Level
Hype check
Tap to vote and see what everyone thinks.
Summary by ByteBrief
